Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Ventricular Tachycardia
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The standard of care for the treatment of Ventricular Tachycardia (VT) comprises of pharmacotherapy, ICD implantation and electrophysiology-guided catheter ablation. The treatment, however, is associated with a relatively high risk of VT recurrence. Given the limited therapeutic options and signific...
The standard of care for the treatment of Ventricular Tachycardia (VT) comprises of pharmacotherapy, ICD implantation and electrophysiology-guided catheter ablation. The treatment, however, is associated with a relatively high risk of VT recurrence. Given the limited therapeutic options and significant impact on patients quality of life, non-invasive cardiac radiosurgery has been recently gaining popularity in scientific literature as a viable alternative to salvage catheter ablations. Considering the scarcity of data from prospective trials and concern about the safety of the treatment method, this trial seeks to determine whether Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia (SMART-VT) meets the expected safety requirements for clinical use.
Tracking Information
- NCT #
- NCT04642963
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: S?awomir Blamek, dr hab. n. med. Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO) Principal Investigator: Wojciech Wojakowski, prof. dr hab. n. med. Upper Silesian Medical Center Professor Leszek Giec of the Medical University of Silesia in Katowice Study Chair: Marcin Miszczyk, dr n. med. Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO)
Get Well Soon